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Objectives: The risk factors for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia
have not been fully characterized and are likely to be different depending on whether infec-
tion is acquired in the community or the hospital.
Methods: We conducted a case-control study of 619 adults hospitalized between 2005 and 2010
with either MRSA or methicillin-sensitive S. aureus (MSSA) pneumonia. Patients with a respira-
tory culture within 48 h of hospitalization had community-onset pneumonia whereas patients
with a culture collected after this time point had hospital-onset pneumonia.
Results: Among patients with community-onset disease, the risk for MRSA was increased by to-
bacco use (OR 2.31, CI 1.23e4.31), chronic obstructive pulmonary disease (OR 3.76, CI 1.74
e8.08), and recent antibiotic exposure (OR 4.87, CI 2.35e10.1) in multivariate analysis while
patients with hospital-onset disease had an increased MRSA risk with tobacco use (OR 2.66, CI
1.38e5.14), illicit drug use (OR 3.52, CI 2.21e5.59), and recent antibiotic exposure (OR 2.04, CI
3.54e13.01). Hospitalization within the prior three months was associated with decreased risk
(OR 0.64, CI 0.46e0.89) in multivariate analysis.
Conclusions: This study suggests there are common and distinct risk factors for MRSA pneu-
monia based on location of onset. The decreased risk for MRSA pneumonia associated with
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associated with MRSA pneumonia depending on whether the infection onset is in the hospital
or in the community. Recent hospitalization was unexpectedly shown to be associated with
decreased risk for MRSA pneumonia and warrants further investigation.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is an
important cause of both hospital-onset and community-
onset pneumonia, associated with increased morbidity and
use of healthcare resources compared to infections caused
by nonresistant strains.1e3 Historically, this infection was
confined largely to the healthcare setting andwas associated
with specific risk factors including recent hospitalization,
recent intravenous antibiotics, residence in a long-term care
facility, dialysis, and indwelling percutaneous catheters.4,5
However, over the past decade, community-onset MRSA in-
fections in patients without traditional risk factors have
emerged.6 Although initially microbiologically and clinically
distinct, the boundaries between hospital-onset and
community-onset MRSA infections have become blurred,
with increasing evidence that community MRSA has spread
into the hospital setting.7,8 Moreover, the ability to distin-
guish these infections and their risk factors has become
increasingly difficult.7e9
Predicting which patients with pneumonia are at risk for
MRSA infection is important since delay in appropriate anti-
biotics may result in increasedmortality andmorbidity while
overuse of empirical broad-spectrum antibiotics can create
multidrug-resistant organisms and contribute to antibiotic-
related complications.10e12 The risk factors for MRSA pneu-
monia, however, have not been fully described and are likely
to bedifferent dependingonwhether infection onset is in the
community or in the hospital.8 13 14 We conducted a case-
control study to determine which risk factors increase the
likelihood of MRSA pneumonia amongst patients with S.
aureus pneumonia. Additionally, we carried out an a priori
subgroup analysis to determine which risk factors were
associated with MRSA pneumonia in patients with
community-onset and hospital-onset S. aureus pneumonia.
Methods
Study subjects
We studied adult patients 18 years of age and older who
were hospitalized at San Francisco General Hospital be-
tween 2005 and 2010 who had either an MRSA or MSSA
respiratory culture (obtained from sputum, tracheal aspi-
rate, bronchoalveolar lavage, or pleural fluid sampling).
Patients were admitted to a variety of services (Internal
Medicine, Surgery, Family Medicine) and to all levels of care
within the hospital (ICU, step-down, floor).
Inclusion criteria
Using modified definitions from the CDC criteria for
healthcare-associated infections, patients with a S. aureusrespiratory culture who had at least three out of four
clinical features of pneumonia (fever, leukocytosis, cough,
and/or opacity on chest X-ray) and/or had a diagnosis of
pneumonia documented in their discharge summary were
included. Cases were defined as patients with the features
listed above and a respiratory culture positive for MRSA;
controls were defined as patients with the features above
and a respiratory culture positive for MSSA.
Exclusion criteria
Patients with a positive S. aureus respiratory culture but
who did not meet the criteria for a diagnosis of pneumonia
were excluded.
Study design
We conducted a case-control study comparing patients with
MRSA pneumonia to those with MSSA pneumonia through a
retrospective chart review. We collected data on de-
mographic features (age, sex, race), homelessness, health-
related behaviors (any history of tobacco use, alcohol use,
or illicit drug use), healthcare-associated features (hospi-
talization at our facility in the past three months and
receipt of antibiotics or steroids as an inpatient at our fa-
cility in the past three months), major medical co-
morbidities as determined by ICD-9 coding, admission to
the ICU, and death at 30 days from diagnosis. We were
unable to obtain data regarding whether patients had been
hospitalized at another facility other than our hospital
within the past 90 days. We also determined whether pa-
tients had community-onset pneumonia (defined as having
a positive respiratory culture sent within 48 h from hospi-
talization) or hospital-onset pneumonia (defined as having a
positive respiratory culture sent after 48 h from admission).
Data on pathogen strain typing and susceptibility patterns
were not available.
Data analysis
We performed bivariate (Fisher’s exact and Chi-square) and
stratified multivariate analyses. All variables that were
statistically significant in bivariate analysis or potentially
important with respect to risk for MRSA were included in
logistic regression analyses. All data were analyzed with
STATA version 9.2.
Results
There were 1143 patients with respiratory cultures positive
for S. aureus between 2005 and 2010. Of these, 619 pa-
tients met criteria for a diagnosis of S. aureus pneumonia
based on the criteria described above. The majority of
Table 2 Adjusted odds ratios for MRSA pneumonia
amongst all patients (N Z 619).
Variable OR (95% CI)
Tobacco use 2.33 (1.45e3.75)*
Illicit drug use 2.72 (1.85e3.99)*
Recent hospitalization 0.15 (0.08e0.26)*
Recent antibiotics 5.13 (3.01e8.76)*
COPD 2.56 (1.40e4.65)*
Liver disease 2.56 (1.40e4.65)*
HIV infection 1.65 (1.05e2.60)*
*P < 0.05.
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use (Table 1). Most had traditional risk factors for hospital-
onset pneumonia; 370 (60%) had been hospitalized in the
past three months, and 232 (37%) had received inpatient
antibiotics during this time period. The majority (81%) of
patients were in the ICU at the time of diagnosis. Of the 619
patients with S. aureus pneumonia, 273 (44%) were infected
with MRSA.
The risk for MRSA pneumonia was significantly increased
for smokers, illicit drug users, patients with COPD, HIV, or
liver disease, and patients who had received inpatient an-
tibiotics within the past three months (Table 1). There was
no difference in admission to the ICU or death at thirty days
in patients infected with MRSA compared to those infected
with MSSA.
In multivariate analysis, tobacco use, drug use, recent
inpatient antibiotic exposure, and COPD independently
increased the risk for MRSA compared to MSSA pneumonia
(Table 2). Thirty-seven percent of patients with S. aureus
pneumonia had community onset disease. For this sub-
group, the risk of MRSA pneumonia was increased by to-
bacco use, COPD, and prior antibiotic exposure in multi-
variate analysis (Table 3). The majority of all patients with
S. aureus pneumonia had hospital onset disease (63%). To-
bacco use, illicit drug use, recent exposure to inpatient
antibiotics, and liver disease significantly increased the risk
for MRSA pneumonia in these patients (Table 4). Interest-
ingly, for patients with community-onset and hospital-onsetTable 1 General characteristics of patients and unadjusted od
Sex Female
Male
Age Mean age
Race White
Non-White
Black
Hispanic
Asian
Other
Health-related behaviors Tobacco use
Alcohol use
Illicit drug use
Housing status Homeless
Setting of infection Community-onset
Hospital-onset
Healthcare associated features Recent hospitalization
Recent antibiotics
Recent steroids
Co-morbidities COPD
Hypertension
Ischemic heart disease
Diabetes
Renal disease
Liver disease
HIV infection
Outcomes ICU admission
Death at 30 days
*P < 0.05.disease, hospitalization in the preceding three months was
associated with a decreased the risk for MRSA (OR 0.46 and
0.50, respectively), even after adjusting for measured
covariates.
Discussion
In this study, we investigated the risk factors for MRSA
pneumonia amongst patients with S. aureus pneumonia,
and we identified specific risk factors for patients who had
community-onset vs. hospital-onset disease. Our results
suggest that the risk factors for MRSA pneumonia may beds ratios for MRSA and MSSA (control) pneumonia (N Z 619).
MRSA (273) Control (346) Unadjusted OR (95% CI)
57 85 0.81 (0.55e1.18)
216 261
54 yr 51 yr 1.01 (0.99e1.01)
107 102 1.28 (0.92e1.79)
183 224
70 65
29 58
26 52
58 49
93 62 2.37 (1.63e3.43)*
60 50 1.53 (0.40e5.10)
115 80 2.42 (1.71e3.42)*
36 34 1.39 (0.84e2.39)
87 105 1.00 (0.70e1.43)
186 241
147 223 0.64 (0.46e0.89)*
121 111 1.69 (1.21e2.34)*
47 47 1.32 (0.85e2.05)
52 27 2.78 (1.69e4.56)*
97 120 1.03 (0.74e1.45)
9 10 1.15 (0.46e2.86)
53 66 1.02 (0.68e1.52)
68 68 1.37 (0.93e1.99)
34 25 1.86 (1.06e3.14)*
74 55 1.96 (1.32e2.91)*
217 282 0.88 (0.59e1.30)
49 43 1.54 (0.98e2.40)
Table 3 Adjusted odds ratios for MRSA pneumonia
amongst patients with community-onset disease (NZ 229).
Variable OR (95% CI)
Tobacco use 2.31 (1.23e4.31)*
Illicit drug use 1.59 (0.87e2.97)
Recent hospitalization 0.16 (0.07e0.35)*
Recent antibiotics 4.87 (2.35e10.1)*
COPD 3.76 (1.74e8.08)*
Liver disease 0.98 (0.39e2.49)
HIV infection 1.40 (0.76e2.59)
*P < 0.05.
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with this infection in the past and that there may be
distinct risk factors for community-onset compared to
hospital-onset infections.
The receipt of inpatient antibiotics at our facility within
the three months prior to infection was the strongest risk
factor for MRSA pneumonia in patients with community and
hospital-onset disease. Prior antibiotic exposure is an
identified risk factor for methicillin-resistance in patients
with S. aureus pneumonia.4 Our findings validate this as a
risk factor and suggest that clinicians should pay particular
attention to this when assessing patients with pneumonia.
Tobacco use independently increased the risk for MRSA
pneumonia in both settings. Smoking tobacco is a well-
established, dose-dependent risk factor for pneumonia,
especially in patients with additional co-morbidities like
HIV infection.15,16 This risk has been described in animal
models and in clinical studies for Streptococcus pneumo-
niae.17 Tobacco-associated injury to the respiratory tract
facilitates bacterial adhesion, invasion, and replication,
thereby increasing susceptibility to MRSA infection; how-
ever, the specific mechanism by which the risk for MRSA is
greater than MSSA is unknown. Similarly, patients with un-
derlying COPD have underlying damage to the respiratory
tract and increased susceptibility, but the reason for a
differential risk with respect to MRSA found in this study is
unclear.
We identified several variables associated with an
increased risk for MRSA pneumonia in patients with
hospital-onset disease. Illicit intravenous drug use is a risk
factor for MRSA skin and soft tissue infections, and someTable 4 Adjusted odds ratios for MRSA pneumonia
amongst patients with hospital-onset pneumonia (NZ 390).
Variable OR (95% CI)
Tobacco use 2.66 (1.38e5.14)*
Illicit drug use 3.52 (2.21e5.59)*
Recent hospitalization 0.12 (0.06e0.24)*
Recent antibiotics 7.01 (3.54e13.01)*
COPD 1.40 (0.56e3.47)
Liver disease 3.50 (1.51e8.11)*
HIV infection 1.63 (0.86e3.11)
*P < 0.05.studies have shown that it is associated with MRSA pneu-
monia.18e20 Our study further supports this finding, sug-
gesting that the presence of illicit drug use should be
considered when starting empirical antibiotics. We also
found that liver disease was independently associated with
increased risk for MRSA pneumonia in patients with
hospital-onset disease. To our knowledge, this association
has not been previously described.
Unexpectedly, the risk for MRSA pneumonia was
decreased in patients who had been hospitalized within the
preceding three months in both the community-onset and
hospital-onset groups. This finding was inconsistent with
our initial hypothesis and with results from prior studies.4,5
There are several possible explanations for our findings.
First, recent studies have shown that the MRSA epidemi-
ology has changed such that specific strains previously seen
only in the community are spreading into the hospital
setting. Neofytos et al. found that 20% of MRSA responsible
for ventilator-associated pneumonia at their institution
were Panton-Valentine-Leukocidin (PVL) positive, a feature
previously seen primarily in community-acquired MRSA in-
fections.21 Second, patients recently hospitalized may be
different in some unmeasured way that protects them from
MRSA infection compared to those without this exposure.
Data on whether patients had been hospitalized recently at
a facility other than our own were unavailable and may
have confound our results however this would not account
for why there was such a high rate of recent hospitalization
amongst those patients with MSSA pneumonia in our patient
population.
There were no differences in risk for ICU admission or
death at 30 days between the MRSA and MSSA group,
regardless of onset of infection. Although other earlier
studies suggested that MRSA infections were associated
with increased mortality, more recent studies demonstrate
similar outcomes in patients with pneumonia after adjust-
ing for confounders and receipt of adequate therapy
upfront.22
There are several limitations to our study, most notably
the retrospective design with its potential to introduce bias
and confounding. Additionally, since we defined hospital-
onset disease by the timing of the culture and not the
development of clinical symptoms, there is the potential
for misclassifying hospital-onset disease as community-
onset and vice versa. Another limitation is the ability to
distinguish patients with true pneumonia vs. patients who
were colonized with S. aureus. Chest X-ray abnormality has
low diagnostic accuracy for VAP and endotracheal micro-
biological sampling shows only 40% agreement with lung
biopsy results.23e25 We attempted to distinguish true S.
aureus pneumonia from S. aureus respiratory tract coloni-
zation by requiring cases and controls to exhibit signs and
symptoms of pneumonia or to have a clinical diagnosis of
pneumonia; however, it is possible that some patients with
colonization and not true infection were included in our
study. Finally, data on S. aureus strain typing was not
available, limiting our ability to analyze the impact of
phenotypic patterns on risk factors and outcomes.
Caution should be used in generalizing these results.
This was a single-center study of patients hospitalized at an
urban county hospital with S. aureus pneumonia. The ma-
jority of the patients who met criteria for the study were in
1270 D.A. Wooten, L.G. Winstonthe ICU, most likely because intubated patients are more
likely to have a respiratory sample sent as part of the work-
up for pneumonia compared to non-intubated patients.
Also S. aureus pneumonia tends to be more severe than
other infectious etiologies.24,26 Thus, the results may not
apply to patients in other settings or to those hospitalized
on a general ward. Additionally, we measured the risk of
MRSA pneumonia compared to MSSA pneumonia, not to
pneumonia from any cause. While this enabled us to control
for unmeasured differences that could have been present in
patients infected with other organisms or who did not have
microbiological data, it limits the ability to apply our re-
sults to patients with all causes of pneumonia.
In conclusion, this study suggests that the traditional risk
factors associated with MRSA pneumonia may be less
applicable and that risk factors may vary for community-
onset vs. hospital-onset disease. Tobacco use appears to be
a more important risk factor than previously described,
whereas recent hospitalization did not confer risk for MRSA
pneumonia. Recent receipt of antibiotics was associated
with significant risk. Using these features, along with
severity of illness, to risk stratify patients may allow for
more appropriate selection of empirical antibiotic therapy.
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